default author photo

Gerald Kevin Oluka

London School of Hygiene & Tropical Medicine - Uganda Research Unit

SCHOLARLY PAPERS

1

DOWNLOADS

112

TOTAL CITATIONS

3

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals

Number of pages: 60 Posted: 19 Feb 2025
Jonathan kitonsa, Jennifer Serwanga, Andrew Abaasa, Jane Lunkuse, Hannah M. Cheeseman, Eugene Ruzagira, Laban Kato, Florence Nambaziira, Gerald Kevin Oluka, Ben Gombe, Sembera Jackson, Joseph Katende Ssebwana, Leon McFarlane, Sarah Joseph, Benjamin Pierce, Robin John Shattock and Pontiano Kaleebu
London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 112 (630,858)
Citation 3

Abstract:

Loading...

Self-amplifying RNA (saRNA) vaccine, SARS-CoV-2 immunogenicity, COVID-19 Vaccination in Africa, Neutralising antibody responses, Spike-specific IgG antibodies, Vaccine safety and reactogenicity, Seronegative vs. seropositive immune response